World J Mens Health.  2015 Dec;33(3):209-213. 10.5534/wjmh.2015.33.3.209.

Impaired Physical Performance and Clinical Responses after a Recreational Bodybuilder's Self-Administration of Steroids: A Case Report

• Veras K
• Silva-Junior FL
• Lima-Silva AE
• De-Oliveira FR
• Pires FO

• KMID: 2405150
• DOI: http://doi.org/10.5534/wjmh.2015.33.3.209

Abstract

We reported clinical and physical responses to 7 weeks of anabolic-androgenic steroid (AAS) self-administration in a male recreational bodybuilder. He was self-administrating a total of 3,250 mg of testosterone when his previous and current clinical and physical trials records were revisited. Body shape, performance, and biochemistry results were clustered into three phases labeled PRE (before the self-use), POST I (immediately at the cessation of the 7-week administration), and POST II (12 weeks after the cessation). Elevated testosterone and estradiol levels were observed in the POST I phase, while hepatic and renal functions remained altered in the POST II phase. Body mass and body fat percentages increased throughout the three phases. When adjusted according to body mass, drops in aerobic and anaerobic power and capacity (2.1% to 12.9%) were observed across the phases. This case report shows that overall performance decreased when a bodybuilding practitioner self-administered AAS.

Keyword

Doping in sports; Lipid metabolism; Strength training; Testosterone

MeSH Terms

Adipose Tissue
Biochemistry
Doping in Sports
Estradiol
Humans
Lipid Metabolism
Male
Resistance Training
Steroids*
Testosterone
Estradiol
Steroids
Testosterone

Reference

1. American College of Sports Medicine position stand on the use of anabolic-androgenic steroids in sports. Med Sci Sports Exerc. 1987; 19:534–539.

2. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004; 34:513–554.

3. Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. Am J Sports Med. 1984; 12:469–484.

4. Kutscher EC, Lund BC, Perry PJ. Anabolic steroids: a review for the clinician. Sports Med. 2002; 32:285–296.

5. Alén M, Häkkinen K. Physical health and fitness of an elite bodybuilder during 1 year of self-administration of testosterone and anabolic steroids: a case study. Int J Sports Med. 1985; 6:24–29.

6. van Breda E, Keizer HA, Kuipers H, Wolffenbuttel BH. Androgenic anabolic steroid use and severe hypothalamicpituitary dysfunction: a case study. Int J Sports Med. 2003; 24:195–196.

7. Hislop MS, St Clair Gibson A, Lambert MI, Noakes TD, Marais AD. Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men. Atherosclerosis. 2001; 159:425–432.

8. Hajimoradi B, Kazerani H. Echocardiographic findings in power athletes abusing anabolic androgenic steroids. Asian J Sports Med. 2013; 4:10–14.

9. Nottin S, Nguyen LD, Terbah M, Obert P. Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging. Am J Cardiol. 2006; 97:912–915.

10. Santos MA, Oliveira CV, Silva AS. Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources. Subst Use Misuse. 2014; 49:1132–1137.